Galmed Pharma today announced that it will host a conference call and webcast to discuss results for the three and nine months ended September 30, 2017 and to provide an update on current developments with respect to its clinical programs for Aramchol on Thursday, November 9, 2017.
November 1, 2017
· 5 min read